Navigation Links
Bavarian Nordic Delivers 1 Million Doses of First Vaccine Developed Under U.S. Biopreparedness Program to the Strategic National Stockpile
Date:7/13/2010

f Health (NIH), for the further development of IMVAMUNE®.  In 2004, Bavarian Nordic was awarded its second U.S. Government contract, valued at $115 million, to continue advanced development of IMVAMUNE® including clinical trials in individuals with compromised immune systems.  In parallel, Bavarian Nordic invested $100 million in the construction of an industrialized manufacturing facility specifically designed to meet the potential demands for IMVAMUNE® by the U.S. Government.

In June 2007, the U.S. Government awarded Bavarian Nordic its third contract for $500 million to manufacture and deliver 20 million doses of IMVAMUNE® for the Strategic National Stockpile.  This contract includes an option to purchase an additional 60 million doses.  In November 2009, BARDA awarded another contract with a prospective value of up to $40 million to Bavarian Nordic for development of a freeze-dried version of IMVAMUNE®.  IMVAMUNE® is the first entirely new biodefense vaccine developed under Project BioShield for inclusion in the Strategic National Stockpile.

BARDA, a division of HHS, manages Project BioShield and is responsible for working with biotechnology and pharmaceutical companies to develop and stockpile effective medicines and vaccines against bioweapons, pandemic influenza, and other emerging infectious diseases.

This release will have no impact on the company's financial guidance for 2010.

Bavarian Nordic: An Established Biodefense Leader

Founded in 1994, Bavarian Nordic is a leading industrial biotechnology company working to target unmet medical needs by developing and pro
'/>"/>

SOURCE Bavarian Nordic
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
2. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
3. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
4. Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety
5. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study
8. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
9. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
10. Vtech(R) Delivers Todays Hottest Trends to Tech-Savvy Kids
11. Hoviones TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Stryker brand ambassadors ... week at the 3M Championship Champions Tour event near ... in Blaine . Stryker is the official joint ... Starting Friday, August 1 st through Sunday, August ... Mobility Zone; an on-site joint health destination located in the Pioneer ...
(Date:7/30/2014)... , July 30, 2014 Silicon Valley Bank, ... a study today that examines the merger, acquisition ... device companies.  According to the annual report based on ... potential returns since SVB started tracking the data in ... IPO.  Built on solid healthcare M&A activity over the ...
(Date:7/30/2014)... YORK , July 30, 2014 ACCESS ... for oncology supportive care, announced that its novel product ... in an article on OncLive.com titled, "Study Finds Mouth ... Cancers."  Dr. Steve Sonis , a leading expert ... seen in the oncology community for evidence-based strategies for ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... the global leader in technology support and BPO services ... today the opening of its new Global Operations Center ... city of Dalian, will specialize in providing services in ... sponsors and clinical research organizations. With dramatic ...
... ARBOR, Mich., April 7, 2011 Adeona Pharmaceuticals, Inc. (AMEX: ... serious central nervous system diseases, announced today that it has ... its common stock at approximately $2.0725 per share to a ... million in gross proceeds. The investor will also receive warrants ...
Cached Medicine Technology:C3i Opens Asia Language Center in Dalian, China 2Adeona to Raise $3.5 Million in Registered Direct Offering 2Adeona to Raise $3.5 Million in Registered Direct Offering 3
(Date:7/30/2014)... 30, 2014 Decene is an ... chain of ten carbon atoms with one double ... of 1-decenes. It can be used as a ... to produce epoxides, amines, oxo alcohols, synthetic lubricants, ... Early buyers will receive 10% customization on this ...
(Date:7/30/2014)... Washington, D.C. (PRWEB) July 30, 2014 ... Community Anti-Drug Coalitions of America (CADCA) , the ... statement in response to the New York Times ... published on Sunday, July 27th. , “CADCA is ... their very public call for national marijuana legalization. The ...
(Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... have recently joined the Board of Directors of ... provides guidance for the Association, which has a ... in healthcare delivery through telecommunications and information technology. ... members of the Association, possess extraordinary expertise and ...
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- Medical costs ... States are more than $32 billion each year, according ... Control and Prevention. The yearly financial toll of ... to reach an estimated $49 billion by 2020. ... for COPD, which provide state public health practitioners with ...
(Date:7/30/2014)... whether a person is at risk for suicide could lie ... Chemical changes to a gene involved in the brain,s response ... the study,s authors explained. Spotting those changes in a blood ... suicide, they said. "Suicide is a major preventable public ... efforts because we have no consistent way to predict those ...
Breaking Medicine News(10 mins):Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:CADCA Responds to New York Times Editorial Board's Call for Marijuana Legalization 2Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Annual COPD Costs To Hit $49 Billion by 2020: CDC 2Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3
... , , , ... month that the first recipients enrolled in Medicare. Now is the time ... for all," said Dr. Jane L. Delgado, President and CEO of the National ... , , "President Obama set out in his ...
... Evidence That Criticisms Are Registering As Debate Intensifies , ... Congress works through specific health reform proposals, the July Kaiser Health Tracking Poll ... reform now, though there is some softening of support as criticisms and doubts ... been the case over the past ten months, a majority of the American ...
... 28th Annual KLOS Blood Drive Aims ... LOS ANGELES, July 22 The American Red Cross and 95.5 KLOS ... Blood Drive. The 2009 KLOS Blood Drive will run for five days, ... and classic rock fans are encouraged to donate at any of the 19 ...
... , INCLINE VILLAGE, Nev., July 22 PDL BioPharma, ... hold a conference call and webcast on Thursday, July 30 at 4:30 p.m. ... and provide a business update. The call and webcast will follow the release ... , , Conference Call Details , ...
... shows devices contain carcinogens, other toxins , WEDNESDAY, ... cigarettes, known as e-cigarettes, has shown that they ... compound used in antifreeze, U.S. health officials said ... cartridges filled with nicotine, flavorings and other chemicals. ...
... WASHINGTON, July 22 There are many provisions in ... care greatly about the freedom to choose their health care. Some of ... * Eliminates Existing Private Insurance Coverage (i.e., Eliminates Your Choice ... But Is Just Fine With You and Your Family) , ...
Cached Medicine News:Health News:Time to Get the Job Done Says Alliance President and CEO 2Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 2Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 3Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 4Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 5Health News:KLOS & Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 2Health News:KLOS & Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 3Health News:PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009 2Health News:E-Cigarettes Pose a Health Hazard, FDA Warns 2Health News:E-Cigarettes Pose a Health Hazard, FDA Warns 3Health News:Mandate for Health Insurance: Inconvenient Truths About How It Will Affect You and Your Family 2
... COMBO 2 Assay is a second generation ... capture for in vitro qualitative detection and ... The assay uses a family of Gen-Probe's ... Amplification (TMA) and Dual Kinetic Assay (DKA). ...
... is a novel device for the ... gonorrhoeae and Neisseria meningitidis. This ... and is easily transportable as a ... incubate and examine the growth of ...
... NearVision™ CK is the only procedure designed for ... and +3.00 D or presbyopic patients who would ... D and 2.25 D to achieve a myopic ... in their non-dominant eye to temporarily improve near ...
... The CC-7000 is a mid range space ... take a non-contact picture of the corneal endothelium ... the corneal thickness in the central area. The ... 9" monitor, which is supplied with the system., ...
Medicine Products: